MicroRNA-195 predicts olanzapine response in drug-free patients with schizophrenia: A prospective cohort study.

Xinxin HuangChenxi BaoQinyu LvJing ZhaoGuoqin HuHaisu WuZezhi LiZhenghui Yi

Published in: Journal of psychopharmacology (Oxford, England) (2020)

Our data indicate that microRNA-195 level may predict symptomatic improvement and olanzapine response in schizophrenia patients, suggesting that microRNA-195 should be considered as a potential therapeutic target for antipsychotics.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
bipolar disorder
prognostic factors
emergency department
machine learning
chemotherapy induced
adverse drug
artificial intelligence